Therapy for multiple sclerosis

Details for Australian Patent Application No. 2005249860 (hide)

Owner Meracol Corporation Limited

Inventors Meakin, Timothy; Cadwallader, Dianne

Agent A J Park

Pub. Number AU-B-2005249860

PCT Pub. Number WO2005/118070

Priority 533370 03.06.04 NZ

Filing date 2 June 2005

Wipo publication date 15 December 2005

Acceptance publication date 20 January 2011

International Classifications

A61P 25/00 (1970.01) Drugs for disorders of the nervous system

A61K 31/20 (2006.01)

A61K 31/23 (2006.01)

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/118070 Priority application(s): WO2005/118070

20 January 2011 Application Accepted

  Published as AU-B-2005249860

19 May 2011 Standard Patent Sealed

3 November 2011 Assignment Registered

  Meracol Corporation Limited The patent has been assigned to Meracol Investments Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005249869-Controlled flow assay device and method

2005249857-Device and method for separating a flowing medium mixture into fractions